Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
Cycle Pharmaceuticals, a privately-owned, global, patient-dedicated biotechnology company focused on developing and delivering medicines for rare diseases, has been featured as one of the Sunday Times 10 Tech Track Ones to Watch 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200907005368/en/
The Sunday Times Tech Track 100 supplement including the 10 Ones to Watch was published on Sunday 6th September 2020, within the business section of the Sunday Times. The digital edition can be downloaded from: www.fasttrack.co.uk .
Earlier this week, Cycle announced a $25m debt financing from Deutsche Bank AG .
About Cycle Pharmaceuticals
Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering best-in-class drug treatments and services to the under-served rare disease patient community. We focus on rare metabolic and neurological genetic conditions. Cycle is headquartered in Cambridge, UK and has offices in Boston, Mass. (USA). For more information, please visit www.cyclepharma.com and follow us on Twitter , LinkedIn , Facebook and Instagram .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-NETAPP20.10.2020 14:02:09 CEST | Press release
NetApp Brings the Simplicity and Flexibility of the Cloud to the Data Center with Updated Software Data Services
CA-VELODYNE-LIDAR,-INC.20.10.2020 14:02:09 CEST | Press release
Velodyne Lidar Calls for Action to Improve Pedestrian Safety
NY-BEHAVOX20.10.2020 14:02:09 CEST | Press release
Danske Bank Enhances Risk Management After Fast-Paced SaaS Implementation of Behavox Compliance Solution
SDS20.10.2020 13:50:08 CEST | Press release
Raiffeisen Banking Group and Banking Technology Partner SDS Announce Joint Future Plans
CA-JSR-LIFE-SCIENCES20.10.2020 13:02:08 CEST | Press release
JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland
WORLD-YOUNG-SCIENTIST20.10.2020 12:40:08 CEST | Press release
2020 World Young Scientist Summit Fosters a Global Youth Community for Science and Innovation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom